Retiring Soon? How to Beat Your Biggest Money Fears
Is 'Good Debt' Ruining Your Chance of Retiring?
How to Have a Successful Money Talk With Your Significant Other
JPMorgan Wants to Mint a Better Bitcoin, & 4 More Things You'll Want to Know Today
4 Speculative Biotech Stocks To Consider
A Candid Conversation With Athersys CEO Gil Van Bokkelen
Athersys: A Significantly Undervalued Stem Cell Company Approaching Key Catalysts
5 Biotech Stocks Under $10 Moving Higher
Stem Cell Therapy Companies: Underappreciated Outperformers
Small-Pharma Watch List: Week Of January 28th
Not really into Drugs? Well, it might be Time!
Top Three Regenerative Medicine Companies Targeting Ischemic Conditions (NAS:ATHX)
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
Athersys: Short Term Catalyst With Long Term Potential